Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-mold Azole Prophylaxis for Invasive Fusariosis
NCT02714504Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Aug 2008
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of voriconazole and posaconazole in invasive fusariosis (IF) (2 arms), sponsored by Federal University of Rio de Janeiro. Primary endpoint: Proportion of Patients Who Develop Invasive Fusariosis Until Neutrophil Recovery. Started Aug 2008; status: completed.
02
Drugs
voriconazoleposaconazole
03
Conditions
invasive fusariosis (IF)
Beyond the preview
Go deeper on NCT02714504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714504.